Terms: = Germ cell tumor AND IL6ST, CDw130, 3572, ENSG00000134352, P40189, IL6R-beta, GP130-RAPS, GP130, CD130 AND Treatment
23 results:
1. Targeting the gp130/STAT3 Axis Attenuates tumor Microenvironment Mediated Chemoresistance in Group 3 Medulloblastoma cells.
Sreenivasan L; Li LV; Leclair P; Lim CJ
Cells; 2022 Jan; 11(3):. PubMed ID: 35159191
[TBL] [Abstract] [Full Text] [Related]
2. Coinhibition of S1PR1 and gp130 by siRNA-loaded alginate-conjugated trimethyl chitosan nanoparticles robustly blocks development of cancer cells.
Rostami N; Nikkhoo A; Khazaei-Poul Y; Farhadi S; Sadat Haeri M; Moghadaszadeh Ardebili S; Aghaei Vanda N; Atyabi F; Namdar A; Baghaei M; Haghnavaz N; Kazemi T; Yousefi M; Ghalamfarsa G; Sabz G; Jadidi-Niaragh F
J Cell Physiol; 2020 Dec; 235(12):9702-9717. PubMed ID: 32424937
[TBL] [Abstract] [Full Text] [Related]
3. Broadening horizons with
Ballal S; Yadav MP; Bal C; Sahoo RK; Tripathi M
Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):934-946. PubMed ID: 31707430
[TBL] [Abstract] [Full Text] [Related]
4. Inhibition of the Invasion of Human Glioblastoma U87 cell Line by Ruxolitinib: A Molecular Player of miR-17 and miR-20a Regulating JAK/STAT Pathway.
Delen E; Doganlar O; Doganlar ZB; Delen O
Turk Neurosurg; 2020; 30(2):182-189. PubMed ID: 31452174
[TBL] [Abstract] [Full Text] [Related]
5. Quercetin abrogates IL-6/STAT3 signaling and inhibits glioblastoma cell line growth and migration.
Michaud-Levesque J; Bousquet-Gagnon N; Béliveau R
Exp Cell Res; 2012 May; 318(8):925-35. PubMed ID: 22394507
[TBL] [Abstract] [Full Text] [Related]
6. Akt signaling pathway: a target for radiosensitizing human malignant glioma.
Chautard E; Loubeau G; Tchirkov A; Chassagne J; Vermot-Desroches C; Morel L; Verrelle P
Neuro Oncol; 2010 May; 12(5):434-43. PubMed ID: 20406894
[TBL] [Abstract] [Full Text] [Related]
7. Interleukin-11 increases invasiveness of JEG-3 choriocarcinoma cells by modulating STAT3 expression.
Suman P; Poehlmann TG; Prakash GJ; Markert UR; Gupta SK
J Reprod Immunol; 2009 Oct; 82(1):1-11. PubMed ID: 19716605
[TBL] [Abstract] [Full Text] [Related]
8. Constitutive suppressor of cytokine signaling 3 expression confers a growth advantage to a human melanoma cell line.
Komyod W; Böhm M; Metze D; Heinrich PC; Behrmann I
Mol Cancer Res; 2007 Mar; 5(3):271-81. PubMed ID: 17374732
[TBL] [Abstract] [Full Text] [Related]
9. Oncostatin M signaling in human glioma cell lines.
Krona A; Järnum S; Salford LG; Widegren B; Aman P
Oncol Rep; 2005 May; 13(5):807-11. PubMed ID: 15809742
[TBL] [Abstract] [Full Text] [Related]
10. Interleukin-1beta can mediate growth arrest and differentiation via the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells.
Park JI; Strock CJ; Ball DW; Nelkin BD
Cytokine; 2005 Feb; 29(3):125-34. PubMed ID: 15613280
[TBL] [Abstract] [Full Text] [Related]
11. Constitutive activation of gp130 leads to neuroendocrine differentiation in vitro and in vivo.
Palmer J; Ernst M; Hammacher A; Hertzog PJ
Prostate; 2005 Feb; 62(3):282-9. PubMed ID: 15389784
[TBL] [Abstract] [Full Text] [Related]
12. Oncostatin-M induction of vascular endothelial growth factor expression in astroglioma cells.
Repovic P; Fears CY; Gladson CL; Benveniste EN
Oncogene; 2003 Nov; 22(50):8117-24. PubMed ID: 14603252
[TBL] [Abstract] [Full Text] [Related]
13. Induction of an interferon-gamma Stat3 response in nerve cells by pre-treatment with gp130 cytokines.
Kaur N; Kim IJ; Higgins D; Halvorsen SW
J Neurochem; 2003 Oct; 87(2):437-47. PubMed ID: 14511121
[TBL] [Abstract] [Full Text] [Related]
14. Initiation and maintenance of CNTF-Jak/STAT signaling in neurons is blocked by protein tyrosine phosphatase inhibitors.
Jiao J; Kaur N; Lu B; Reeves SA; Halvorsen SW
Brain Res Mol Brain Res; 2003 Aug; 116(1-2):135-46. PubMed ID: 12941469
[TBL] [Abstract] [Full Text] [Related]
15. Oncostatin M enhances the expression of prostaglandin E2 and cyclooxygenase-2 in astrocytes: synergy with interleukin-1beta, tumor necrosis factor-alpha, and bacterial lipopolysaccharide.
Repovic P; Mi K; Benveniste EN
Glia; 2003 Jun; 42(4):433-46. PubMed ID: 12730964
[TBL] [Abstract] [Full Text] [Related]
16. Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.
Halfter H; Postert C; Friedrich M; Ringelstein EB; Stögbauer F
Brain Res Mol Brain Res; 2000 Sep; 80(2):198-206. PubMed ID: 11038252
[TBL] [Abstract] [Full Text] [Related]
17. Growth inhibition of newly established human glioma cell lines by leukemia inhibitory factor.
Halfter H; Kremerskothen J; Weber J; Hacker-Klom U; Barnekow A; Ringelstein EB; Stögbauer F
J Neurooncol; 1998 Aug; 39(1):1-18. PubMed ID: 9760066
[TBL] [Abstract] [Full Text] [Related]
18. Effects of oncostatin M and tamoxifen on human melanoma cells.
Gibbs P; Chen Q; Robinson WA
Melanoma Res; 1998 Jun; 8(3):221-6. PubMed ID: 9664143
[TBL] [Abstract] [Full Text] [Related]
19. Opposing regulation of ciliary neurotrophic factor receptors on neuroblastoma cells by distinct differentiating agents.
Malek RL; Halvorsen SW
J Neurobiol; 1997 Jan; 32(1):81-94. PubMed ID: 8989665
[TBL] [Abstract] [Full Text] [Related]
20. IL-6 antisense-mediated growth inhibition of a choriocarcinoma cell line: an intracellular autocrine growth mechanism.
Kong B; Isozaki T; Sasaki S
Gynecol Oncol; 1996 Oct; 63(1):78-84. PubMed ID: 8898173
[TBL] [Abstract] [Full Text] [Related]
[Next]
